Zhejiang Wolwo Bio-Pharmaceutical (300357) Key Financial Indicators

24.72
+0.03+0.12%

Market Closed Mar 11 15:00 CST

12.94BMarket Cap33.14P/E (TTM)

300357 Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Zhejiang Wolwo Bio-Pharmaceutical shows that the company's current ratio is 14.78, indicating healthy liquidity.

Currency: CNY

Cumulative Quarterly

300357 Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Zhejiang Wolwo Bio-Pharmaceutical, the quick ratio is 14.33, indicating that the company can meet its short-term debt obligations.

Currency: CNY

Cumulative Quarterly

300357 Return on Equity (ROE)

Want to learn more about the financial health of Zhejiang Wolwo Bio-Pharmaceutical? The latest ROE figure is 13.82%, indicating that the company has stable profitability.

Currency: CNY

Cumulative Quarterly

300357 Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Zhejiang Wolwo Bio-Pharmaceutical, the total asset return on investment (ROA) is 11.97%.

Currency: CNY

Cumulative Quarterly

300357 Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Zhejiang Wolwo Bio-Pharmaceutical's latest financial report to see how their gross margin is doing - currently at 95.37%.

Currency: CNY

Cumulative Quarterly

300357 Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Zhejiang Wolwo Bio-Pharmaceutical, the net profit margin is 39.28%, which is a good sign for its profitability.

Currency: CNY

Cumulative Quarterly

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Recently, the ongoing conflict between the US and Iran has continued to impact the stock market. Previously, there were indications that Tru Show More

富哥搞钱

Feb 28 17:22

Breaking! The US and Israel jointly bombed Iran. What will be the stock market trend next week?

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.